BridgeBio is substantially improved its progress of a new therapy for amyloid heart disease, employing the investigational drug. Preliminary clinical data indicates potential outcomes for individuals suffering with this https://bridgebio238417.livebloggs.com/48922404/bridgebio-advances-amyloidosis-treatment-through-the-drug